
1. toxicol appl pharmacol. 2008 mar 1;227(2):196-206. epub 2007 nov 1.

ligand-dependent interactions ah receptor coactivators mammalian
two-hybrid assay.

zhang s(1), rowlands c, safe s.

author information: 
(1)department veterinary physiology pharmacology, texas a&m university,
college station, tx 77843, usa.

2,3,7,8-tetrachlorodibenzo-p-dioxin (tcdd) high affinity ligand aryl
hydrocarbon receptor (ahr). study, investigated structure-dependent
differences activation ahr series halogenated aromatic
hydrocarbons. tcdd, 1,2,3,7,8-pentachlorodibenzo-p-dioxin (pecdd),
2,3,7,8-tetrachlorodibenzofuran (tcdf), 2,3,4,7,8-pentachlorodibenzofuran
(pecdf), 3,3',4,4',5-pentachlorobiphenyl (pcb126) induced cyp1a1-dependent
activities hek293 human embryonic kidney, panc1 pancreatic cancer, and
hepa1c1c7 mouse hepatoma cell lines. structure-dependent difference
in efficacy tcdf pcb126 hek293 panc1 cells since induced cyp1a1
mrna levels lower observed congeners. mammalian
two-hybrid assay cells transfected gal4-coactivator ahr-vp16 chimeras
was used investigate structure-dependent interactions chimeras in
panc1, hek293, hepa1c1c7 cells. reporter construct pgal4-luc contains
five tandem gal4 response elements linked luciferase gene the
gal4-coactivator chimeras express several coactivators including steroid receptor
coactivator 1 (src-1), src-2 src-3, mediator coactivator trap220,
coactivator associated arginine methyl transferase 1 (carm-1), peroxisome
proliferator-activated receptor gamma coactivator 1 (pgc-1). results the
mammalian two-hybrid studies clearly demonstrate activation pgal4-luc 
cells transfected vp-ahr gal4-coactivator chimeras dependent the
structure hah congener, cell context, coactivator, suggesting the
prototypical hah congeners used study exhibit selective ahr modulator
activity.

doi: 10.1016/j.taap.2007.10.019 
pmcid: pmc2288743
pmid: 18048071  [indexed medline]

